-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
-
-
-
-
-
-
-
Cantor Fitzgerald Says Phathom Pharmaceuticals (PHAT) is Top Pick After Focusing on GI
-
-
-
-
-
-
-
Phathom Pharmaceuticals (PHAT) PT Raised to $12 at Goldman Sachs
-
-
-
-
-
-
-
Phathom Pharmaceuticals (PHAT) Petition Granted by FDA
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
-
416,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

